Business Name: |
Iraklii Buziashvili Md |
Address: |
785 Park Avenue, New York City, New York 10021 |
Phone Number: |
(212) 288-8382 |
Annual Revenue (USD): |
$100.000 to $499.999 |
Founding Year: |
2014 |
Location Type: |
Single Location |
Employee Number: |
1 to 4 |
Business Type: |
B2C (Business to Consumer) |
Business Category: |
Doctors |
SIC Code: |
8011 |
NAICS Code: |
621111 |
Share This Business: |
|
Related Businesses: |
Anita Ronis Lcsw P C - New York City, NY 10021 Andre Carasca Neurology Pllc - New York City, NY 10021 Alexander Simotas - New York City, NY 10021 Amar Lal Purohit MD - New York City, NY 10021 Aguiar Cassyanne L MD - New York City, NY 10021 Barbuto Joseph MD - New York City, NY 10021 Aelion Anate MD - New York City, NY 10021 Barnett Dermatology - New York City, NY 10021 Aston Plastic Surgery Service Inc - New York City, NY 10021 Alfred J Kaltman Md - New York City, NY 10021 Ann Griffin - New York City, NY 10021 Annetta Nadler Dr - New York City, NY 10021 Andrew W Lyons Md - New York City, NY 10021 A H Samiy - New York City, NY 10021 Albert B Knapp Dr - New York City, NY 10021 Alan B Bergman MD - New York City, NY 10021 Nicholas Bastidas MD - New York City, NY 10021 Arthur M Perlman MD - New York City, NY 10021 72 St Medical Assoc - New York City, NY 10021 Ari Kiev Md - New York City, NY 10021 |
The company Iraklii Buziashvili Md provides B2C services in the form of Doctors from its single location in New York.
1 to 4 employees work for Iraklii Buziashvili Md, and the business now earns $100.000 to $499.999 per annum.
Iraklii Buziashvili Md was launched in 2014 and is classified under SIC code and category 8011 , and NAICS number and grouping 621111 .
To contact Iraklii Buziashvili Md, please call with the phone number (212) 288-8382 or visit its single location at 785 Park Avenue in New York City, New York 10021.
The location of the single location can also be found using the coordinates .
Read more details about this business on the webpage or follow the company’s social media accounts, on Twitter and on Facebook.